daniel drucker glp 1 You may know Ozempic or Wegovy, but did you know Drucker’s groundbreaking work on glucagon-like peptide-1 (GLP-1) is what makes them possible?, Daniel Drucker, physician, senior investigator at Daniel J. Drucker, MD |

Always consult your healthcare provider before combining medications to make sure the pairing is safe and effective for your needs

Accessed on May 14, 2025 at Read next Which GLP-1 medication is most effective for weight loss

doi: 10.1017/S0007114517000496 163 MazzoneL.DoolingS

10.1016/j.jclinane.2023.111091 [DOI] [PubMed] 13.Imeryz N, Yeen BC, Bozkurt A, Cokun T, Villanueva-Peacarrillo ML, Ulusoy NB (1997) Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms

We found that, from a healthcare perspective, use of SGLT2is is probably cost-effective in both populations

Compounded GLP-1 formulations, which may be used for microdosing, carry additional risks, including uncertain drug quality and imprecise dosing that may be especially dangerous for people who also take insulin